Table 2.
Imaging findings on 68Ga-DOTATATE PET/CT compared to prior imaging studies and type and number of confirmed or tentative changes to clinical management
| Imaging findings | # Patients, % |
|---|---|
| Patients with prior imaging | 63 |
| Concordant | 42 (66.7) |
| Discordant & new | 21 (33.3) |
| Confirmed or tentative changes in clinical management | |
| Follow-up imaging | 6 (9.5) |
| Treatment change | 15 (23.8) |
| Medical | 9 (14.3) |
| PRRT | − 7 (11.1) |
| Chemotherapy (everolimus) | − 1 (1.6) |
| Octreotide agonist (sandostatin) | − 1 (1.6) |
| Surgical | 6 (9.5) |
| Thyroidectomy | − 1 (1.6) |
| Partial/total pancreatectomy | − 3 (4.8) |
| Small bowel/ mesentery resection | − 1 (1.6) |
| Surgery cancelation | − 1 (1.6) |